This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kyprianou, N. Articles by Benning, C. M. Search for Related Content PubMed PubMed Citation Articles by Kyprianou, N. Articles by Benning, C. M.

Suppression of Human Prostate Cancer Cell Growth By 1-Adrenoceptor Antagonists Doxazosin and Terazosin via Induction of Apoptosis¹

Division of Urology, Department of Biochemistry and Molecular Biology, and University of Maryland Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201

Recent evidence from our laboratory has demonstrated that 1-adrenoceptor antagonists doxazosin and terazosin induced apoptosis in prostate epithelial and smooth muscle cells in patients with benign prostatic hypertrophy (BPH; J. Urol., 159: 1810–1815, 1998; J. Urol., 161: 2002–2007, 1999). In this study, we investigated the biological action of three 1-adrenoceptor antagonists, doxazosin, terazosin, and tamsulosin, against prostate cancer cell growth. The antigrowth effect of the three 1-adrenoceptor antagonists was examined in two human prostate cancer cell lines, PC-3 and DU-145, and a prostate smooth muscle cell primary culture, SMC-1, on the basis of: (a) cell viability assay; (b) rate of DNA synthesis; and (c) induction of apoptosis. Our results indicate that treatment of prostate cancer cells with doxazosin or terazosin results in a significant loss of cell viability, via induction of apoptosis in a dose-dependent manner, whereas tamsulosin had no effect on prostate cell growth. Neither doxazosin nor terazosin exerted a significant effect on the rate of cell proliferation in prostate cancer cells. Exposure to phenoxybenzamine, an irreversible inhibitor of 1-adrenoceptors, does not abrogate the apoptotic effect of doxazosin or terazosin against human prostate cancer or smooth muscle cells. This suggests that the apoptotic activity of doxazosin and terazosin against prostate cells is independent of their capacity to antagonize 1-adrenoceptors. Furthermore, an in vivo efficacy trial demonstrated that doxazosin administration (at tolerated pharmacologically relevant doses) in SCID mice bearing PC-3 prostate cancer xenografts resulted in a significant inhibition of tumor growth. These findings demonstrate the ability of doxazosin and terazosin (but not tamsulosin) to suppress prostate cancer cell growth in vitro and in vivo by inducing apoptosis without affecting cell proliferation. This evidence provides the rationale for targeting both drugs, already in clinical use and with established adverse-effect profiles, against prostatic tumors for the treatment of advanced prostate cancer.

This article has been cited by other articles:

				M. Saleem, I. Murtaza, R. S. Tarapore, Y. Suh, V. M. Adhami, J. J. Johnson, I. A. Siddiqui, N. Khan, M. Asim, B. B. Hafeez, et al. Lupeol inhibits proliferation of human prostate cancer cells by targeting {beta}-catenin signaling Carcinogenesis, May 1, 2009; 30(5): 808 - 817. [Abstract] [Full Text] [PDF]

				S. Thebault, M. Flourakis, K. Vanoverberghe, F. Vandermoere, M. Roudbaraki, V. Lehen'kyi, C. Slomianny, B. Beck, P. Mariot, J.-L. Bonnal, et al. Differential Role of Transient Receptor Potential Channels in Ca2+ Entry and Proliferation of Prostate Cancer Epithelial Cells Cancer Res., February 15, 2006; 66(4): 2038 - 2047. [Abstract] [Full Text] [PDF]

				M. A. Fernando and A. P. Heaney {alpha}1-Adrenergic Receptor Antagonists: Novel Therapy for Pituitary Adenomas Mol. Endocrinol., December 1, 2005; 19(12): 3085 - 3096. [Abstract] [Full Text] [PDF]

				S. Debrus, L. Rahbani, M. Marttila, B. Delorme, P. Paradis, and M. Nemer The Zinc Finger-Only Protein Zfp260 Is a Novel Cardiac Regulator and a Nuclear Effector of {alpha}1-Adrenergic Signaling Mol. Cell. Biol., October 1, 2005; 25(19): 8669 - 8682. [Abstract] [Full Text] [PDF]

				J. R. Gonzalez-Juanatey, M. J. Iglesias, C. Alcaide, R. Pineiro, and F. Lago Doxazosin Induces Apoptosis in Cardiomyocytes Cultured In Vitro by a Mechanism That Is Independent of {alpha}1-Adrenergic Blockade Circulation, January 7, 2003; 107(1): 127 - 131. [Abstract] [Full Text] [PDF]

				C. M. Benning and N. Kyprianou Quinazoline-derived {alpha}1-Adrenoceptor Antagonists Induce Prostate Cancer Cell Apoptosis Via an {alpha}1-Adrenoceptor-independent Action Cancer Res., January 1, 2002; 62(2): 597 - 602. [Abstract] [Full Text] [PDF]

				F. H. Messerli Doxazosin and congestive heart failure J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1295 - 1296. [Abstract] [Full Text] [PDF]